Carlos Juan
Carlos Juan
Immunology associate professor (UIB), Microbiology Researcher Hospital Son Espases, Palma
Verified email at uib.cat
Title
Cited by
Cited by
Year
The increasing threat of Pseudomonas aeruginosa high-risk clones
A Oliver, X Mulet, C López-Causapé, C Juan
Drug Resistance Updates 21, 41-59, 2015
3792015
β-Lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein
B Moya, A Dötsch, C Juan, J Blázquez, L Zamorano, S Haussler, A Oliver
PLoS Pathog 5 (3), e1000353, 2009
2402009
Molecular epidemiology and mechanisms of carbapenem resistance in Pseudomonas aeruginosa isolates from Spanish hospitals
O Gutiérrez, C Juan, E Cercenado, F Navarro, E Bouza, P Coll, JL Pérez, ...
Antimicrobial agents and chemotherapy 51 (12), 4329-4335, 2007
2302007
Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance
A Doménech-Sánchez, L Martínez-Martínez, S Hernández-Allés, ...
Antimicrobial agents and chemotherapy 47 (10), 3332-3335, 2003
211*2003
Genetic markers of widespread extensively drug-resistant Pseudomonas aeruginosa high-risk clones
G Cabot, AA Ocampo-Sosa, MA Domínguez, JF Gago, C Juan, F Tubau, ...
Antimicrobial agents and chemotherapy 56 (12), 6349-6357, 2012
1992012
Molecular mechanisms of β-lactam resistance mediated by AmpC hyperproduction in Pseudomonas aeruginosa clinical strains
C Juan, MD Maciá, O Gutiérrez, C Vidal, JL Pérez, A Oliver
Antimicrobial agents and chemotherapy 49 (11), 4733-4738, 2005
1952005
Extended-spectrum β-lactamase-producing Escherichia coli in Spain belong to a large variety of multilocus sequence typing types, including ST10 complex/A, ST23 complex/A and …
J Oteo, K Diestra, C Juan, V Bautista, Â Novais, M Pérez-Vázquez, ...
International journal of antimicrobial agents 34 (2), 173-176, 2009
1722009
Stepwise upregulation of the Pseudomonas aeruginosa chromosomal cephalosporinase conferring high-level β-lactam resistance involves three AmpD homologues
C Juan, B Moyá, JL Pérez, A Oliver
Antimicrobial agents and chemotherapy 50 (5), 1780-1787, 2006
1722006
Pseudomonas aeruginosa carbapenem resistance mechanisms in Spain: impact on the activity of imipenem, meropenem and doripenem
E Riera, G Cabot, X Mulet, M García-Castillo, R del Campo, C Juan, ...
Journal of antimicrobial chemotherapy 66 (9), 2022-2027, 2011
1662011
Pseudomonas aeruginosa ceftolozane-tazobactam resistance development requires multiple mutations leading to overexpression and structural modification of AmpC
G Cabot, S Bruchmann, X Mulet, L Zamorano, B Moyà, C Juan, ...
Antimicrobial agents and chemotherapy 58 (6), 3091-3099, 2014
1602014
Hypermutation and the preexistence of antibiotic-resistant Pseudomonas aeruginosa mutants: implications for susceptibility testing and treatment of chronic infections
A Oliver, BR Levin, C Juan, F Baquero, J Blázquez
Antimicrobial agents and chemotherapy 48 (11), 4226-4233, 2004
1492004
Evolution of Pseudomonas aeruginosa antimicrobial resistance and fitness under low and high mutation rates
G Cabot, L Zamorano, B Moyà, C Juan, A Navas, J Blázquez, A Oliver
Antimicrobial agents and chemotherapy 60 (3), 1767-1778, 2016
1292016
Pan-β-lactam resistance development in Pseudomonas aeruginosa clinical strains: molecular mechanisms, penicillin-binding protein profiles, and binding affinities
B Moyá, A Beceiro, G Cabot, C Juan, L Zamorano, S Alberti, A Oliver
Antimicrobial agents and chemotherapy 56 (9), 4771-4778, 2012
1212012
Nosocomial spread of colistin-only-sensitive sequence type 235 Pseudomonas aeruginosa isolates producing the extended-spectrum β-lactamases GES-1 and GES-5 in Spain
E Viedma, C Juan, J Acosta, L Zamorano, JR Otero, F Sanz, F Chaves, ...
Antimicrobial agents and chemotherapy 53 (11), 4930-4933, 2009
1122009
Metallo-β-lactamase-producing Pseudomonas putida as a reservoir of multidrug resistance elements that can be transferred to successful Pseudomonas aeruginosa clones
C Juan, L Zamorano, A Mena, S Albertí, JL Pérez, A Oliver
Journal of antimicrobial chemotherapy 65 (3), 474-478, 2010
1102010
Activity of a new cephalosporin, CXA-101 (FR264205), against β-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of …
B Moya, L Zamorano, C Juan, JL Pérez, Y Ge, A Oliver
Antimicrobial agents and chemotherapy 54 (3), 1213-1217, 2010
1052010
Affinity of the new cephalosporin CXA-101 to penicillin-binding proteins of Pseudomonas aeruginosa
B Moya, L Zamorano, C Juan, Y Ge, A Oliver
Antimicrobial agents and chemotherapy 54 (9), 3933-3937, 2010
1002010
Biological markers of Pseudomonas aeruginosa epidemic high-risk clones
X Mulet, G Cabot, AA Ocampo-Sosa, MA Domínguez, L Zamorano, ...
Antimicrobial agents and chemotherapy 57 (11), 5527-5535, 2013
972013
Benefit of having multiple ampD genes for acquiring β-lactam resistance without losing fitness and virulence in Pseudomonas aeruginosa
B Moya, C Juan, S Alberti, JL Pérez, A Oliver
Antimicrobial agents and chemotherapy 52 (10), 3694-3700, 2008
952008
Characterization of the new metallo-β-lactamase VIM-13 and its integron-borne gene from a Pseudomonas aeruginosa clinical isolate in Spain
C Juan, A Beceiro, O Gutiérrez, S Albertí, M Garau, JL Pérez, G Bou, ...
Antimicrobial agents and chemotherapy 52 (10), 3589-3596, 2008
952008
The system can't perform the operation now. Try again later.
Articles 1–20